200 related articles for article (PubMed ID: 18219099)
21. Anxiety, depression and quality of life (QoL) in patients with chronic dizziness.
Cheng YY; Kuo CH; Hsieh WL; Lee SD; Lee WJ; Chen LK; Kao CL
Arch Gerontol Geriatr; 2012; 54(1):131-5. PubMed ID: 21561671
[TBL] [Abstract][Full Text] [Related]
22. Psychiatric and otologic diagnoses in patients complaining of dizziness.
Sullivan M; Clark MR; Katon WJ; Fischl M; Russo J; Dobie RA; Voorhees R
Arch Intern Med; 1993 Jun; 153(12):1479-84. PubMed ID: 8512438
[TBL] [Abstract][Full Text] [Related]
23. Chronic subjective dizziness: Analysis of underlying personality factors.
Chiarella G; Petrolo C; Riccelli R; Giofrè L; Olivadese G; Gioacchini FM; Scarpa A; Cassandro E; Passamonti L
J Vestib Res; 2016 Nov; 26(4):403-408. PubMed ID: 27814314
[TBL] [Abstract][Full Text] [Related]
24. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder.
Escalona R; Canive JM; Calais LA; Davidson JR
Depress Anxiety; 2002; 15(1):29-33. PubMed ID: 11816050
[TBL] [Abstract][Full Text] [Related]
25. Psychiatric comorbidity and psychosocial impairment among patients with vertigo and dizziness.
Lahmann C; Henningsen P; Brandt T; Strupp M; Jahn K; Dieterich M; Eckhardt-Henn A; Feuerecker R; Dinkel A; Schmid G
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):302-8. PubMed ID: 24963122
[TBL] [Abstract][Full Text] [Related]
26. Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety.
Simon NM; Pollack MH; Tuby KS; Stern TA
Ann Clin Psychiatry; 1998 Jun; 10(2):75-80. PubMed ID: 9669539
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
Ueda N; Yoshimura R; Shinkai K; Nakamura J
Pharmacopsychiatry; 2002 Sep; 35(5):175-81. PubMed ID: 12237788
[TBL] [Abstract][Full Text] [Related]
28. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
Dalery J; Honig A
Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
[TBL] [Abstract][Full Text] [Related]
29. Episodic versus Chronic Dizziness: An Analysis of Predictive Factors.
Formeister EJ; Chae R; Wong E; Chiao W; Pasquesi L; Sharon JD
Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):403-411. PubMed ID: 34121469
[TBL] [Abstract][Full Text] [Related]
30. Psychiatric disorders in patients with dizziness and Ménière's disease.
Kanzaki J; Goto F
Acta Otolaryngol; 2015 May; 135(5):447-50. PubMed ID: 25678073
[TBL] [Abstract][Full Text] [Related]
31. The effect of vestibular rehabilitation on sleep disturbance in patients with chronic dizziness.
Sugaya N; Arai M; Goto F
Acta Otolaryngol; 2017 Mar; 137(3):275-278. PubMed ID: 27758126
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Contributing Factors of Anxiety and Depression in Patients with Vestibular Migraine.
Kim TS; Lee WH; Heo Y
Ear Nose Throat J; 2024 May; 103(5):305-312. PubMed ID: 37329273
[No Abstract] [Full Text] [Related]
33. Effect of anxiety on antero-posterior postural stability in patients with dizziness.
Goto F; Kabeya M; Kushiro K; Ttsutsumi T; Hayashi K
Neurosci Lett; 2011 Jan; 487(2):204-6. PubMed ID: 20951766
[TBL] [Abstract][Full Text] [Related]
34. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
Zohar J; Keegstra H; Barrelet L
Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological and clinical aspects of fluvoxamine (Depromel), the first selective serotonin reuptake inhibitor approved for clinical use employed in Japan].
Hachisu M; Ichimaru Y
Nihon Yakurigaku Zasshi; 2000 May; 115(5):271-9. PubMed ID: 10872178
[TBL] [Abstract][Full Text] [Related]
36. Clinical study on the efficacy of fluvoxamine for psychological distress in gynecologic cancer patients.
Suzuki N; Ninomiya M; Maruta T; Hosonuma S; Yoshioka N; Ohara T; Nishigaya Y; Kobayashi Y; Kiguchi K; Ishizuka B
Int J Gynecol Cancer; 2011 Aug; 21(6):1143-9. PubMed ID: 21792017
[TBL] [Abstract][Full Text] [Related]
37. Influence of vestibular disease on psychological distress: a multicenter study.
Hong SM; Lee HJ; Lee B; Park SK; Hong SK; Park IS; Kim YB; Kim HJ
Otolaryngol Head Neck Surg; 2013 May; 148(5):810-4. PubMed ID: 23380760
[TBL] [Abstract][Full Text] [Related]
38. [Chronic subjective dizziness].
Lin Y; Wang JL; Qiu JH; Zha DJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):869-872. PubMed ID: 27938621
[TBL] [Abstract][Full Text] [Related]
39. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
[TBL] [Abstract][Full Text] [Related]
40. Dizziness handicap and anxiety depression among patients with benign paroxysmal positional vertigo and vestibular migraine.
Zhu C; Li Y; Ju Y; Zhao X
Medicine (Baltimore); 2020 Dec; 99(52):e23752. PubMed ID: 33350759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
